Mathematical Modeling of Vaccines That Prevent SARS-CoV-2 Transmission

SARS-CoV-2 vaccine clinical trials assess efficacy against disease (VE(DIS)), the ability to block symptomatic COVID-19. They only partially discriminate whether VE(DIS) is mediated by preventing infection completely, which is defined as detection of virus in the airways (VE(SUSC)), or by preventing...

Descripción completa

Detalles Bibliográficos
Autores principales: Swan, David A., Goyal, Ashish, Bracis, Chloe, Moore, Mia, Krantz, Elizabeth, Brown, Elizabeth, Cardozo-Ojeda, Fabian, Reeves, Daniel B., Gao, Fei, Gilbert, Peter B., Corey, Lawrence, Cohen, Myron S., Janes, Holly, Dimitrov, Dobromir, Schiffer, Joshua T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539635/
https://www.ncbi.nlm.nih.gov/pubmed/34696352
http://dx.doi.org/10.3390/v13101921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539635/
https://www.ncbi.nlm.nih.gov/pubmed/34696352
http://dx.doi.org/10.3390/v13101921

Ejemplares similares